Results 11 to 20 of about 18,220 (284)
Ligelizumab for Chronic Spontaneous Urticaria [PDF]
New England Journal of Medicine, 2019 In the majority of patients with chronic spontaneous urticaria, most currently available therapies do not result in complete symptom control. Ligelizumab is a next-generation high-affinity humanized monoclonal anti-IgE antibody. Data are limited regarding the dose-response relationship of ligelizumab and the efficacy and safety of ligelizumab as ...
Marcus Maurer +26 more
exaly +8 more sources
Benralizumab for Chronic Spontaneous Urticaria
New England Journal of Medicine, 2020 Benralizumab for Chronic Spontaneous Urticaria Benralizumab, an anti–interleukin-5-receptor antibody, was evaluated in a 24-week study involving 12 patients with chronic spontaneous urticaria.
Jonathan A. Bernstein +5 more
openaire +3 more sources
Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study, [PDF]
Anais Brasileiros de Dermatologia, 2021 Background: The pathophysiology of urticaria is still poorly understood. Recent studies demonstrate that the activation of coagulation is correlated with the clinical activity of Chronic Spontaneous Urticaria.
Roberta Fachini Criado +5 more
doaj +1 more source
Chronic spontaneous urticaria [PDF]
Canadian Medical Association Journal, 2016 Patients present with recurrent, pruritic, wheal-and-flare lesions that fade within 24 hours without scarring.[1][1] The condition can occur with angioedema in 30%–50% of patients and should be differentiated from acute urticaria (lasting < 6 weeks) and physically induced urticaria (e.g., by ...
Jane, Hsieh, Jason K, Lee
openaire +3 more sources
Indian Journal of Dermatology, 2022 Importance: Exact etiopathogenesis of chronic spontaneous urticaria (CSU) remains elusive. Infections, pseudoallergens, autoimmunity, and contact sensitization are various postulated factors. Few studies are available measuring cytokine levels in CSU.
Apoorva Maheshwari +3 more
openaire +3 more sources
SAGE Open Medical Case Reports, 2022 Several therapeutic strategies have been established to achieve maximal remission and improve quality of life in patients with chronic spontaneous urticaria.
Armin Abadeh, Jason Kihyuk Lee
doaj +1 more source
Association between Clinico-epidemiological Features in Chronic Urticaria with Autologous Serum Skin Test: A Cross-sectional Observational Study [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Urticaria is a frequent and heterogeneous skin disease characterised by the development of wheals (hives), angioedema, or both. Chronic urticaria is characterised by the occurrence of wheals lasting less than 24 hours, with or without ...
Usha Rani Tirupathi +2 more
doaj +1 more source
CHRONIC AUTOIMMUNE URTICARIA IN CHILDREN
Slovenska pediatrija, 2021 Urticaria is a common disease in childhood, characterised by the appearance of a transient itchy nettle rash on the skin, which may be accompanied by angioedema.
Lana Stergar +2 more
doaj +1 more source
Chronic inducible urticaria: confirmation through challenge tests and response to treatment
Einstein (São Paulo), 2020 Objective To evaluate the positivity of challenge tests of patients suspected of chronic inducible urticaria and the response to treatment. Methods A retrospective study of electronic medical records of patients suspected of chronic inducible ...
Amanda Rocha Firmino Pereira +3 more
doaj +2 more sources
Brain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2020 ‘Kounis Syndrome’ is an acute coronary artery event due to an artery spasm occurring during immediate hypersensi- tivity reactions or chronic spontaneous urticaria. Recently it has been reported in other systems, including the cerebral vasculature.
Luis Santiago, Margarida Gonçalo
doaj +1 more source